European private equity is narrowing on three fronts at once: capital is flowing to fewer managers, liquidity is coming from fewer exits, and returns depend on fewer levers. For LPs and GPs, the test is no longer access to a buoyant market but the ability to return cash.
Slowing, Not Stalling
European private equity enters the final quarter of 2026 in a more demanding mood than the headlines suggest. PitchBook’s Q3 data show deal value down 11% quarter-on-quarter and exit value down 25%, a slowdown it ties largely to the cost of money after two ECB rate hikes, in June and September. Pricing, though, has moved in buyers’ favour. The median European EV/EBITDA multiple has slipped to 8.9x from 9.8x in 2025.
Europe has also gained ground on the US. In Q2, European deal value rose while US deal value fell 44.3%, and the US lead in deal value narrowed from 57% in 2025 to roughly 35% in the first half. Beneath that resilience, the market is going through what we call the Great Narrowing, on three fronts: capital is concentrating in fewer managers, liquidity in fewer exits, and returns in the few levers sponsors still control.
The First Narrowing: Capital
PitchBook counts €65.9 billion raised across 99 funds so far this year, against €84.8 billion across 174 funds in all of 2025. That equals 78% of last year’s capital from 57% of the fund count. In the words of PitchBook analyst Nicolas Moura, LPs are “consolidating around fewer, larger managers.” Established firms took 89% of capital raised, first-time fundraising has stalled, and funds of €1 billion to €5 billion accounted for 54.1% of capital raised in the first half.
LP behaviour explains why. Canadian pension funds are leading the consolidation trend, with British Columbia Investment Management cutting GP relationships by at least half. Moonfare’s analysis puts the share of recent commitments going to existing GP relationships at around 70%. It also notes, citing Bain, that distributions have stayed below 15% of NAV for four straight years, so LPs are prioritising realised returns over paper marks. EY argues that after four consecutive years of falling fundraising, “scale has become a survival requirement.” In its view, mid-market firms must differentiate sharply by sector or geography, merge into a larger platform or face a slow fade.
There is a say-do gap here. IPEM’s 2026 survey found LPs strongly signalling a desire to back new GP relationships over re-ups, with attendees hoping to make more than 3,300 such commitments in the next 12 months. AlixPartners’ Nicolas Beaugrand notes that more senior investors than ever are leaving to launch their own firms, “the most in the history of private equity.” Yet the capital data show that intent running into the limits of LP capacity and distributions.
Even established names are not immune. Astorg’s flagship has struggled to raise since its November 2025 launch despite managing €24 billion and targeting a relatively modest €4 billion. Investors cite its inability to exit IQ-EQ. Other 2025-vintage flagships, including EQT XI, Permira IX, Nordic Capital XII and Bridgepoint Europe VIII, were still open at the end of June. The Netherlands offers a counterweight: APG expects to lift its private markets allocation from about 26% to about 30% over five years as Dutch pension reform redirects capital, giving local managers a growing domestic LP base.
The Second Narrowing: Liquidity
Europe’s exit data look strong until you look at who is exiting. Q2 exit value surged 29.7% to a three-year high, but just 22 mega-exits drove 65.8% of it, against a decade average of 43.6%. PitchBook reads this as a clearing event for sponsors with marquee assets rather than a broad liquidity recovery.
TK Elevator is the template. Advent and Cinven sold it to Kone for €29.4 billion, roughly €12 billion of value creation since carving it out of Thyssenkrupp for €17.2 billion in 2020. As the Financial Times put it, the sponsors “followed the private equity playbook to the letter.” Few assets fit that mould. Both of Q2’s flagship European IPOs listed in the US, corporate buyers took 53.4% of exit value, and GP-led secondary transactions slipped to 64 in the first half from 73 a year earlier.
The deals-to-exit ratio tells the same story: 2.9x in the first half of 2026, up from 2.4x in 2025, so new deals are being struck faster than existing ones are realised. Valuation discipline is now part of the debate. At SuperReturn, Apollo’s Scott Kleinman argued the industry would need to capitulate on valuations after years of overpaying in the 2017–2022 vintages. At the opposite extreme, Thoma Bravo handed Medallia to its lenders, wiping out a $5 billion equity position.
GPs face a bind. An ILPA poll cited in Bain’s mid-year report found that a majority of LPs begin losing confidence in a GP once an exit prices 5% or more below the last reported valuation. The price flexibility needed to clear inventory pulls against the trust needed to raise the next fund. Astorg shows the loop in action: stalled exits constrain the fundraising that depends on them, because LPs withhold recommitments until cash comes back.
The Third Narrowing: Value Creation
The old playbook is also getting harder to run. Bain told SuperReturn that a business needing 5% EBITDA growth to hit target returns a decade ago now needs 12%, given today’s entry multiples and rates. Alvarez & Marsal draws the practical conclusion: sponsors “can no longer buy and wait for multiple expansion to do the work.” Its analysis of 250 European exits found margin improvement now accounts for half of EBITDA growth, more than double the share for exits through 2023. The share of firms embedding AI in value creation plans rose from 41% to 63%, and those deploying resources mainly in the first 100 days doubled from 29% to 58%.
Entry points are improving for those who can deploy. Take-private value reached €52.8 billion year to date, up 32%, with the UK accounting for close to 60%. Pantheon’s Imogen Richards argues the mid-market remains 1.8 times cheaper than large-cap equivalents. One caution: deals with US investor participation reached a record 46% of European deal value in Q3, so much of the market’s resilience is imported rather than homegrown.
What LPs and GPs Should Ask
For LPs, the practical response is to look past headline exit values and ask how broad the liquidity really is. What share of realisations came from outside the largest deals? How much depends on continuation vehicles or sales to corporates at prices below the last mark? Where does the manager’s own distribution record sit against the four-year drought in industry-wide distributions, and what happens to the next re-up if it slips?
On value creation, the questions are just as direct. How much of the underwritten return relies on multiple expansion rather than margin and cash conversion? What does the plan look like if rates stay high and exits take longer?
For GPs, the mirror image applies. Fundraising now rewards a visible record of returned capital over narrative, and scale or sharp specialisation over the middle ground. Managers who can show realisations, disciplined marks and operational delivery will keep winning capital in a narrower market.
The defining question for European private equity is no longer whether capital and deals are available. It is whether a market narrowing this fast can still return cash broadly enough to keep LPs coming back.
